Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Niiki Pharma
Hoboken, New Jersey, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Niiki Pharma developed first-in-class targeted cancer therapeutics focused on novel cellular targets. The company advanced several small molecule candidates into early clinical development, with the highest stage reaching Phase 2. Most pipeline programs were ultimately discontinued or remain pending further development.
- Therapeutic areas
- OncologyEndocrinology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Ben Franklin Technology Partners of Southeastern PABioAdvance
Beyond the preview
Go deeper on Niiki Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Niiki Pharma.